ViroPharma beats Street

ViroPharma Inc. (NASDAQ:VPHM) reported 3Q10 diluted GAAP EPS of $0.45, beating by $0.14 the Street's estimate of $0.31 and up 88% from $0.24 in 3Q09. Revenues for the quarter were $117.8 million, up 4...